Patents Represented by Attorney Florek & Endres PLLC
-
Patent number: 8343532Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavorings, taste masking agents, colorings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.Type: GrantFiled: September 6, 2004Date of Patent: January 1, 2013Assignee: Arrow No. 7 LimitedInventors: Anders Dam, Janos Major, Peter Tasco
-
Patent number: 8329922Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.Type: GrantFiled: December 13, 2011Date of Patent: December 11, 2012Assignee: Arrow International LimitedInventors: Kailan Zhou, Hong Liu, Zhirong Chen, Huabin Hong, Yang Sun, Yunde Wang, Jiangchun Pan
-
Patent number: 8318304Abstract: An intumescent rod comprising an intumescent component formed of an intumescent material and a polymer matrix. The intumescent rod may include a second component forming a covering, core or layer adjacent the intumescent component. A method for manufacturing an intumescent rod including molding or extrusion of at least one of an intumescent component and an optional second component.Type: GrantFiled: November 24, 2009Date of Patent: November 27, 2012Assignee: Alva-Tech, Inc.Inventor: Philip F. Valenziano
-
Patent number: 8309125Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.Type: GrantFiled: July 14, 2010Date of Patent: November 13, 2012Assignee: Watson Pharmaceuticals, Inc.Inventors: Unchalee Kositprapa, Avinash Nangia, John Cardinal, Robert I. Goldfarb
-
Patent number: 8309104Abstract: The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administration.Type: GrantFiled: February 28, 2007Date of Patent: November 13, 2012Assignee: Watson Pharmaceuticals, Inc.Inventors: Xiu Xiu Cheng, Dacheng Tian
-
Patent number: 8298559Abstract: A physical mode of action pesticide for application on plants and in soils, and methods of manufacture and application, comprising an active ingredient in the form of a polymer in a concentration of less than 0.1% wt., a surfactant, a co-solvent and a diluent in a hydrocolloid suspension. The suspension polymer is preferably a polysaccharide having a molecular weight of 10,000 to 25,000,000, and preferably in the range of about 600,000. The pesticide preferably also includes a targeting ingredient for directing the active ingredient to a particular target.Type: GrantFiled: July 9, 2009Date of Patent: October 30, 2012Inventors: Brook Chandler Murphy, Todd C. Steckler
-
Patent number: 8277433Abstract: An ampoule made of plasties material, for liquid or suspension pharmaceuticals, has a reservoir linked to a removable head by a channel in a neck portion. The channel has a trap, thus located between its reservoir and the head, in the form of an elongated restriction and/or a bend to trap liquid or suspension which may settle during storage, and prevent either reaching the head.Type: GrantFiled: November 22, 2007Date of Patent: October 2, 2012Assignee: Breath Ltd.Inventors: Ian Gardner Cameron McAffer, Peter Ernest Tasko
-
Patent number: 8258322Abstract: An improved process is provided for the synthesis of hexahydrodibenzo[b,d]pyran-9-ones, such as nabilone.Type: GrantFiled: August 28, 2009Date of Patent: September 4, 2012Assignee: Watson Laboratories, Inc.Inventors: Valeriy Mikaylo, Subakar Paramanantham, Ilya Avrutov, Martyn A. Brown, Zemin Li, Natalie Lazarowych
-
Patent number: 8252327Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.Type: GrantFiled: July 11, 2011Date of Patent: August 28, 2012Assignee: Andrx Pharmaceuticals, Inc.Inventors: Manesh Dixit, Chih-Ming Chen, Xiu-Xiu Cheng, Jianbo Xie
-
Patent number: 8241662Abstract: The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma concentration of oxybutynin metabolites, such as N-desethyloxybutynin, which is presumed to be contributing at least in part to some of the adverse drug experiences, while maintaining sufficient oxybutynin plasma concentration to benefit a subject with oxybutynin therapy. The invention also provides isomers of oxybutynin and its metabolites that meet these characteristics of minimized incidence and/or severity of adverse drug experiences, and maintenance of beneficial and effective therapy for overactive bladder. In some aspects, the composition may be presented in the form of an unoccluded or free form topically administered gel.Type: GrantFiled: December 21, 2006Date of Patent: August 14, 2012Assignee: Watson Laboratories, Inc.Inventors: Charles D. Ebert, Steven W. Sanders
-
Patent number: 8207470Abstract: Provided is an apparatus for generating remote plasma, which can improve thin-film quality by preventing an arc at a bias electrode. The apparatus includes a radio frequency (RF) electrode installed inside an upper portion of a chamber, a bias electrode installed apart from the RF electrode, and including a plurality of through holes through which plasma passes, wherein a bias power is supplied to the bias electrode, a plasma generating unit formed between the RF electrode and the bias electrode, wherein a plasma gas is supplied to the plasma generating unit, and a ground electrode installed under and spaced apart from the bias electrode, and including plasma through holes corresponding to the through holes of the bias electrode, wherein a pulsed DC bias of a second voltage level, which has a first voltage level periodically, is applied to the bias electrode.Type: GrantFiled: August 25, 2009Date of Patent: June 26, 2012Assignee: Industry-University Cooperation Foundation Hanyang UniversityInventors: Hyeong-Tag Jeon, Sang-Hyun Woo, Hyung-Chul Kim, Chin-Wook Chung
-
Patent number: 8206792Abstract: A method for forming a ceramic containing composite structure is proposed comprising the steps of (a) feeding a ceramic component that sublimes and a metallic or semi-conductor material that does not sublime into a thermal spray apparatus, (b) spraying the ceramic component and the metallic or semi-conductor material onto a substrate, whereby the ceramic component and the metallic or semi-conductor material deposit on the surface of the substrate, and (c) keeping the metallic or semi-conductor material on the substrate surface plastic during spraying at least in the region where the metallic or semi-conductor material actually strikes the surface.Type: GrantFiled: March 20, 2006Date of Patent: June 26, 2012Assignee: Sulzer Metco (US) Inc.Inventors: David S. Gollob, Thomas H. Piquette, James Derby, Omar Basil Al-Sabouni, Richard Karl Schmid, Jacobus Cornelis Doesburg
-
Patent number: 8173637Abstract: A pharmaceutical composition that contains an atypical antipsychotic drug and succinic acid, fumaric acid or a mixture of succinic acid and fumaric acid.Type: GrantFiled: September 5, 2008Date of Patent: May 8, 2012Assignee: Handa Pharmaceuticals, LLCInventors: Fang-yu Liu, Zhi-qun Shen
-
Patent number: 8151987Abstract: A peelable pouch comprises a substantially flat enclosure formed by first and second opposing flexible plies. A seat extends along at least a portion of a perimeter of the opposing plies. A flat, flexible transdermal patch is disposed in the enclosure and includes a bioactive agent dissolved in a layer of adhesive. A release liner is removably attached over the layer of adhesive, with the patch and the release liner together being sufficiently resilient so as to generate a spring force when displaced out of the flat configuration. The first and the second plies each being separable along the seal and displaceable out of the flat configuration. The spring force generated by the patch and the release liner being sufficient to overcome an adhesive force created by the adhesive between the patch and one of the plies.Type: GrantFiled: February 28, 2011Date of Patent: April 10, 2012Assignee: Watson Laboratories, Inc.Inventor: Michael W. Kimball
-
Patent number: 8128469Abstract: An interactive media system configured to present a substantially real-time simulation of an actual live event involving a moveable object in an arena, the system comprising: a tag attachable to a moveable object involved in an actual live event in an arena; one or more base stations located relative to the arena and operable to receive a signal from the tag; a location platform configured to determine the location of the tag in the arena based on the signal received from the tag by the or each base station, and to output location data representing a location of the tag in the arena; a virtual world environment unit to simulate the actual live event including the arena, the object, and movement of the object in the arena using the location data for the tag; and an access interface in communication with the virtual world environment unit, the access interface being arranged to provide a user with access to the simulated arena and to permit the user to observe the simulated event in substantially real-time.Type: GrantFiled: March 5, 2009Date of Patent: March 6, 2012Assignee: Virtually Live Ltd.Inventors: Jesus Hormigo Cebolla, Jamil Nadim El Imad
-
Patent number: 8119552Abstract: The present invention relates to a catalyst composition for the reaction of hydrocarbons comprising a zeolite with has a faujasite structure and a fibrous zeolite which comprises essentially non-crossing one-dimensional channels. Further, the catalyst composition comprises in a preferred embodiment a metal component selected from metals of the group VIB and VIII of the periodic table of elements and their compounds. The invention relates further to a process for the synthesis of such a catalyst composition and to a process for hydrocracking hydrocarbon feedstocks by using said catalyst composition.Type: GrantFiled: October 26, 2006Date of Patent: February 21, 2012Assignee: Süd-Chemie AGInventors: Götz Burgfels, Stephan Wellach, Josef Schönlinner, Friedrich Schmidt, Volker Kurth, Vebjorn Knut Grande, Jorunn Steinsland Rosvoll, Per Aksel Skjølsvik
-
Patent number: 8114509Abstract: A gas permeable membrane for the optical measurement of the partial pressure and/or the concentration of a gas species, the membrane comprises a porous light-transmissible membrane matrix containing a metal oxide, wherein the membrane matrix is at least partially charged with at least one gas-selective compound whose optical characteristics change upon an interaction with a corresponding gas species.Type: GrantFiled: May 10, 2006Date of Patent: February 14, 2012Assignees: Eidgenossische Technische Hochschule Zurich, Universidad De GranadaInventors: Ursula Spichiger-Keller, Stephan Spichiger, Jorge Fernando Fernandez-Sanchez
-
Patent number: D657500Type: GrantFiled: December 16, 2010Date of Patent: April 10, 2012Inventor: David Gellis
-
Patent number: D672200Type: GrantFiled: May 4, 2012Date of Patent: December 11, 2012Assignee: Robinson Home Products, Inc.Inventors: Stuart Harvey Lee, Jochen Schaepers
-
Patent number: RE43885Abstract: A practice drumhead assembly including a mesh membrane held in substantially fixed relation to an acoustic membrane. The assembly preferably includes an annular tensioning ring for tensioning the mesh membrane, and an engagement member for substantially fixing the mesh membrane relative to the acoustic membrane. The tensioning ring includes a cylindrical rod with a turnbuckle that is rotated to increase the diameter of the tensioning ring.Type: GrantFiled: April 6, 2011Date of Patent: January 1, 2013Inventors: Thomas Rogers, Raymond F. Gastgeb